ASN: eGFR No Different With Sparsentan, Irbesartan in Focal Segmental Glomerulosclerosis

WEDNESDAY, Nov. 8, 2023-- No significant differences are seen in the estimated glomerular filtration rate (eGFR) with sparsentan versus irbesartan among patients with focal segmental glomerulosclerosis (FSGS), according to a study published online...